BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35995203)

  • 1. Sphingosylphosphorylcholine ameliorates doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by reducing excessive mitophagy and mitochondrial dysfunction.
    Zhou J; Lu Y; Li Z; Wang Z; Kong W; Zhao J
    Toxicol Appl Pharmacol; 2022 Oct; 452():116207. PubMed ID: 35995203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway.
    Yin J; Guo J; Zhang Q; Cui L; Zhang L; Zhang T; Zhao J; Li J; Middleton A; Carmichael PL; Peng S
    Toxicol In Vitro; 2018 Sep; 51():1-10. PubMed ID: 29729358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
    Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
    J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy.
    Catanzaro MP; Weiner A; Kaminaris A; Li C; Cai F; Zhao F; Kobayashi S; Kobayashi T; Huang Y; Sesaki H; Liang Q
    FASEB J; 2019 Oct; 33(10):11096-11108. PubMed ID: 31291545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
    Chen B; Zhang JP
    Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis.
    Li W; Zhang Y; Wang X; Cao J; Qian W; Ling G; Tan N; Jiang J; Sun Q; Li C; Wang W; Wang Y
    Oxid Med Cell Longev; 2022; 2022():4344677. PubMed ID: 36120600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
    Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
    Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Rubicon ameliorates doxorubicin-induced cardiotoxicity through enhancement of mitochondrial quality.
    Liu X; Zhang S; An L; Wu J; Hu X; Lai S; Mazhar H; Zou Y; He L; Zhu H
    Int J Cardiol; 2019 Dec; 296():129-135. PubMed ID: 31439425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
    Kanno SI; Hara A
    Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
    Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
    Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells.
    Hu B; Zhen D; Bai M; Xuan T; Wang Y; Liu M; Yu L; Bai D; Fu D; Wei C
    J Ethnopharmacol; 2022 Apr; 288():114936. PubMed ID: 35007682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity.
    Wu L; Wang L; Du Y; Zhang Y; Ren J
    Trends Pharmacol Sci; 2023 Jan; 44(1):34-49. PubMed ID: 36396497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
    Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
    Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
    Koleini N; Kardami E
    Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follistatin-like protein 1 attenuates doxorubicin-induced cardiomyopathy by inhibiting MsrB2-mediated mitophagy.
    Lu L; Shao Y; Wang N; Xiong X; Zhai M; Tang J; Liu Y; Yang J; Yang L
    Mol Cell Biochem; 2024 May; ():. PubMed ID: 38696001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of COX5A protects H9c2 cells against doxorubicin-induced cardiotoxicity.
    Zhang P; Chen Z; Lu D; Wu Y; Fan M; Qian J; Ge J
    Biochem Biophys Res Commun; 2020 Mar; 524(1):43-49. PubMed ID: 31980176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.